Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus
Clinical trial NCT03920267 · COMPLETED
Trial details
- NCT number
- NCT03920267
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2025-03-21
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.